Successful treatment of cutaneous metastatic melanoma with high-dose intralesional interleukin-2 treatment combined with cryosurgery

Dermatol Ther. 2018 Jul;31(4):e12612. doi: 10.1111/dth.12612. Epub 2018 May 15.

Authors

Antonio Martinez-Lopez¹, Francisco Manuel Almazan-Fernandez², Israel Perez-Lopez³, Paula Aguayo-Carreras⁴, Luis Salvador-Rodriguez¹, Carlos Cuenca-Barrales⁴, Salvador Arias-Santiago^{1

5}

Affiliations

¹ Dermatology Unit, Hospital Universitario Virgen de las Nieves, Granada, Spain.
² Melanoma Unit, Hospital Universitario San Cecilio, Granada, Spain.
³ Dermatology Unit, Hospital de Baza, Granada, Spain.
⁴ Dermatology Unit, Hospital Universitario San Cecilio, Granada, Spain.
⁵ Medicine School, University of Granada, Spain.

PMID: 29766618
DOI: 10.1111/dth.12612

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents / administration & dosage*
Biopsy
Chemotherapy, Adjuvant
Cryosurgery*
Humans
Injections, Intralesional
Interleukin-2 / administration & dosage*
Lymph Node Excision
Lymphatic Metastasis
Male
Melanoma / secondary
Melanoma / therapy*
Skin Neoplasms / pathology
Skin Neoplasms / therapy*
Treatment Outcome

Substances

Antineoplastic Agents
Interleukin-2